ESR1 and ovarian cancer: This contrasts with, e.g., breast and ovarian cancers, where estrogen signaling through estrogen receptor α (ERα) promotes tumorigenesis, as in the colon, estrogen receptor β (ERβ) predominates and has a protective role linked to anti-proliferative and pro-apoptotic effects [11].